Skip to main content
. 2022 Feb 11;13(2):884–893. doi: 10.1002/jcsm.12925

Table 1.

Baseline characteristics of the participants

Variable Control group (N = 100) Intervention group (N = 88)
Demographic data
Age, years 84.0 (4.8) 84.2 (4.8)
Women, N (%) 69 (69.0%) 63 (71.6%)
Body mass index, kg/m 2 27.0 (4.3) 27.1 (3.6)
Education, N (%)
<12 years 80 (80.0%) 67 (76.1%)
≥12 years 20 (20.0%) 21 (23.9%)
Living status, N (%)
Alone 26 (26.0) 19 (21.6)
Caregivers 12 (12.0) 9 (10.2)
Family members 60 (60.0) 58 (65.9)
Others 2 (2.0) 2 (2.3)
Clinical data
MCI, N (%) 63 (63.0) 49 (55.7)
Mild dementia, N (%) 37 (37.0) 38 (43.2)
Fried criteria, N (%)
Prefrail (1–2 points) 64 (64.0) 57 (64.8)
Frail (3–5 points) 36 (36.0) 31 (35.2)
CIRS score, median (IQR) 5.0 (5.0) 7.0 (6.0)
MNA score, median (IQR) 13.0 (3.0) 13.0 (3.0)
1RM leg press, kg 49.4 (27.2) 48.0 (24.1)
5 m GVT, s 7.8 (2.9) 8.7 (5.5)
Primary endpoint measures
SPPB scale, score 7.7 (2.5) 6.8 (2.7)
Secondary endpoint measures
MOCA, score 15.4 (5.2) 15.8 (5.2)
MEC Lobo, score 27.1 (4.5) 26.4 (5.3)
Barthel Index, score 91.7 (10.2) 91.1 (9.3)
Handgrip, kg 19.2 (7.7) 19.6 (6.7)
Yesavage GDS, score 3.4 (2.9) 3.9 (2.9)
QoL (EQ‐VAS), score 71.4 (18.2) 70.6 (20.6)

Data are mean (SD) unless otherwise stated. Significant differences were found between groups for SPPB score and CIRS score (P < 0.05).

CIRS, Cumulative Illness Rating Scale; EQ‐VAS, Visual analog scale of the EuroQol questionnaire; GVT, Gait Velocity Test; IQR, interquartile range; MNA, Mini‐Nutritional Assessment; MCI, Mild Cognitive Impairment; MEC, Minimental Cognitive Exam; MOCA, Montreal Cognitive Assessment; QoL, Quality of Life; SPPB, Short Physical Performance Battery; Yesavage GDS, Yesavage Geriatric Depression Scale; 1RM, one‐repetition maximum.